The global exosome therapy market is projected to grow from $32 million in 2026 to $1.4 billion by 2040, with a CAGR of 41.1%. Key growth drivers include expanding clinical pipelines, increased regulatory filings, and rising investment in regenerative medicine. Ophthalmology and oncology represent major therapeutic areas, while Asia-Pacific is positioned as a leading market. However, challenges include inconsistent therapeutic preparations, contamination risks, and quality control complexities.
The global drug reconstitution systems market is expected to grow at a 7.0% CAGR from $5.9 billion in 2026 to $10.8 billion by 2035, driven by expanding biologic and biosimilar pipelines, increasing demand for safer drug delivery systems, and the shift toward home healthcare and self-administered therapies. Cartridges lead the market at 50% revenue share, while prefilled syringes are expected to grow faster. Asia-Pacific is projected to achieve the fastest regional growth.
The global drug repurposing market is projected to grow from USD 34.79 billion in 2025 to USD 50.91 billion by 2035 at a CAGR of 3.93%. North America leads with 39% market share, while Asia-Pacific shows the fastest growth at 5.02% CAGR. Small molecules dominate at 67% market share, with oncology and neurology as primary therapeutic areas. AI and machine learning are accelerating drug discovery, though intellectual property rights remain a key barrier.
ResearchAndMarkets.com released a comprehensive analytical tool tracking CAR/TCR/TIL therapies in oncology, monitoring 870+ organizations and 2,370+ drugs across the pipeline. The tool provides competitive intelligence on leading developers including Gilead Sciences, Cellectis, MediGene, GenScript, and CARsgen Therapeutics, with 236 new therapies added in 2024/25 and over 1,700 BD&L contacts for partnership opportunities.
The global Quick Service Restaurants market is projected to grow from USD 1,064.44 billion in 2025 to USD 2,462.71 billion by 2035 at an 8.75% CAGR. Digital ordering and delivery services now account for 48% of QSR sales, with online orders exceeding 120 billion globally. North America leads with 34.65% market share, while Asia Pacific emerges as the fastest-growing region at 9.96% CAGR. Major players are investing in digital innovation, mobile apps, and contactless services to capture growing consumer demand for convenience.
A comprehensive 249-page veterinary diagnostics market report covering 15 countries and 32 companies has been released, forecasting market trends through 2030. The report analyzes growth drivers including pet ownership patterns, agricultural modernization, and the One Health movement, while examining competitive positioning of major players like IDEXX, Zoetis, Antech, Roche, and Thermo Fisher across various diagnostic assay types, animal categories, and applications.